TY - JOUR
T1 - American Heart Association Cardiogenic Shock Registry
T2 - Design and Implementation
AU - Morrow, David A.
AU - Jessup, Mariell
AU - Abraham, William T.
AU - Acker, Michael
AU - Aringo, Angeline
AU - Batchelor, Wayne
AU - Chikwe, Joanna
AU - Costello, Shaina
AU - Drakos, Stavros G.
AU - Farmer, Steven
AU - Gelijns, Annetine
AU - Gillette, Nicole
AU - Hochman, Judith S.
AU - Isler, Maria
AU - Kapur, Navin K.
AU - Kilic, Arman
AU - Kormos, Robert
AU - Lewis, Eldrin F.
AU - Lindenfeld, Joann
AU - Lombardi, Pierluca
AU - Mancini, Donna
AU - Rao, Sunil V.
AU - Rutan, Christine
AU - Samsky, Marc
AU - Krucoff, Mitchell W.
N1 - Publisher Copyright:
© 2024 American Heart Association, Inc.
PY - 2024/7/1
Y1 - 2024/7/1
N2 - BACKGROUND: Cardiogenic shock is a morbid complication of heart disease that claims the lives of more than 1 in 3 patients presenting with this syndrome. Supporting a unique collaboration across clinical specialties, federal regulators, payors, and industry, the American Heart Association volunteers and staff have launched a quality improvement registry to better understand the clinical manifestations of shock phenotypes, and to benchmark the management patterns, and outcomes of patients presenting with cardiogenic shock to hospitals across the United States. METHODS: Participating hospitals will enroll consecutive hospitalized patients with cardiogenic shock, regardless of etiology or severity. Data are collected through individual reviews of medical records of sequential adult patients with cardiogenic shock. The electronic case record form was collaboratively designed with a core minimum data structure and aligned with Shock Academic Research Consortium definitions. This registry will allow participating health systems to evaluate patient-level data including diagnostic approaches, therapeutics, use of advanced monitoring and circulatory support, processes of care, complications, and in-hospital survival. Participating sites can leverage these data for onsite monitoring of outcomes and benchmarking versus other institutions. The registry was concomitantly designed to provide a high-quality longitudinal research infrastructure for pragmatic randomized trials as well as translational, clinical, and implementation research. An aggregate deidentified data set will be made available to the research community on the American Heart Association's Precision Medicine Platform. On March 31, 2022, the American Heart Association Cardiogenic Shock Registry received its first clinical records. At the time of this submission, 100 centers are participating. CONCLUSIONS: The American Heart Association Cardiogenic Shock Registry will serve as a resource using consistent data structure and definitions for the medical and research community to accelerate scientific advancement through shared learning and research resulting in improved quality of care and outcomes of shock patients.
AB - BACKGROUND: Cardiogenic shock is a morbid complication of heart disease that claims the lives of more than 1 in 3 patients presenting with this syndrome. Supporting a unique collaboration across clinical specialties, federal regulators, payors, and industry, the American Heart Association volunteers and staff have launched a quality improvement registry to better understand the clinical manifestations of shock phenotypes, and to benchmark the management patterns, and outcomes of patients presenting with cardiogenic shock to hospitals across the United States. METHODS: Participating hospitals will enroll consecutive hospitalized patients with cardiogenic shock, regardless of etiology or severity. Data are collected through individual reviews of medical records of sequential adult patients with cardiogenic shock. The electronic case record form was collaboratively designed with a core minimum data structure and aligned with Shock Academic Research Consortium definitions. This registry will allow participating health systems to evaluate patient-level data including diagnostic approaches, therapeutics, use of advanced monitoring and circulatory support, processes of care, complications, and in-hospital survival. Participating sites can leverage these data for onsite monitoring of outcomes and benchmarking versus other institutions. The registry was concomitantly designed to provide a high-quality longitudinal research infrastructure for pragmatic randomized trials as well as translational, clinical, and implementation research. An aggregate deidentified data set will be made available to the research community on the American Heart Association's Precision Medicine Platform. On March 31, 2022, the American Heart Association Cardiogenic Shock Registry received its first clinical records. At the time of this submission, 100 centers are participating. CONCLUSIONS: The American Heart Association Cardiogenic Shock Registry will serve as a resource using consistent data structure and definitions for the medical and research community to accelerate scientific advancement through shared learning and research resulting in improved quality of care and outcomes of shock patients.
KW - benchmarking
KW - cardiogenic shock
KW - heart diseases
KW - precision medicine
KW - quality improvement
UR - http://www.scopus.com/inward/record.url?scp=85198701288&partnerID=8YFLogxK
U2 - 10.1161/CIRCOUTCOMES.123.010637
DO - 10.1161/CIRCOUTCOMES.123.010637
M3 - Article
C2 - 38887950
AN - SCOPUS:85198701288
SN - 1941-7713
VL - 17
JO - Circulation: Cardiovascular Quality and Outcomes
JF - Circulation: Cardiovascular Quality and Outcomes
IS - 7
M1 - e010637
ER -